This decision depends on individual health status, goals achieved, habits established, and presence of obesity-related conditions
Most compounded semaglutide formulations receive a BUD of 30 to 90 days from the date of compounding
What plans want to see: Specific dates of participation in a structured program Nutrition counseling sessions (provider visits, dietitian visits) Documented exercise regimen with duration and frequency Weight history with specific dates and values Previous weight-loss medication trials and outcomes App-based program participation (Noom, MyFitnessPal, Weight Watchers, etc.) Behavioral changes attempted with specific calorie reduction targets If your plan requires this documentation and you have not yet completed it, completing and documenting it now is often faster than fighting the denial
It tends to resolve as the body adapts, usually within the first few weeks to a month
Retatrutide and exercise body composition refers to the effects retatrutide, a recent drug, and exercise have on muscle, fat, and body shape
doi: 10.3389/fphar.2022.1026182